Qualigen Therapeutics Inc expected to post a loss of 19 cents a share - Earnings Preview

Aixcrypto Holdings

08/11/2021 11:23

* Qualigen Therapeutics Inc  QLGN.OQ   QLGN.O  is expected
to report results on November 10 (estimated).
* The Los Angeles, California-based company is expected to
report revenue of $1.341 million, according to the mean estimate
from 2 analysts, based on Refinitiv data.  
​* Refinitiv's mean analyst estimate for Qualigen Therapeutics
Inc is for a loss of 19 cents per share. 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Qualigen
Therapeutics Inc is $7.75​, about 85.2% above​ its last closing
price of $1.15. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Jun. 30 2021  -0.16       -0.16      -0.18     Missed  -12.5
 Mar. 31 2021  -0.14       -0.14      -0.13     Beat    7.1
                                                        ​
 ​​                                                     
                                                        ​
 Dec. 31 2019              -1.50      -0.95     Beat    36.7
 Sep. 30 2019  -5.75       -5.75      -5.75     Met     0
 This summary was machine generated November 8 at 11:23 GMT.  All
figures in US dollars unless otherwise stated